Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar + cisplatin-based CCRT in stage IIB–IIIB cervical cancer
ChiCTR-OIC-17012754Phase 2Recruiting
- Sponsor
- Sichuan Cancer Hospital
- Start
- Nov 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of endostar in Cervical Cancer (CC), sponsored by Sichuan Cancer Hospital. Primary endpoints: Adverse Event, Serious Adverse Event and 1 more. Started Nov 2017; status: recruiting.
02
Drugs
endostar
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR-OIC-17012754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIC-17012754.